What is Epitope Diagnostics?
Epitope Diagnostics Inc. is a certified medical device manufacturer based in San Diego, California, specializing in niche immunoassays. The company's product portfolio includes ELISA kits, rapid tests, and antibodies, catering to professional laboratories in fields such as oncology, infectious diseases, and autoimmune disorders. With ISO13485:2016 certification and US FDA registration, Epitope Diagnostics is committed to delivering high-quality diagnostic solutions for the global clinical diagnostics and research communities, aiming to provide innovative and reliable testing platforms.
How much funding has Epitope Diagnostics raised?
Epitope Diagnostics has raised a total of $1.5M across 1 funding round:
Debt
$1.5M
Debt (2024): $1.5M with participation from Bank of America
Key Investors in Epitope Diagnostics
Bank of America
Bank of America is a leading global financial institution providing a wide range of banking and financial services. Their participation in this funding round likely indicates a strategic debt financing arrangement to support Epitope Diagnostics' operational expansion and capital expenditure needs.
What's next for Epitope Diagnostics?
The recent major strategic investment positions Epitope Diagnostics for significant scaling and further development of its diagnostic solutions. This enterprise-level backing suggests a focus on expanding market reach, enhancing research and development capabilities, and potentially exploring new therapeutic areas or technological advancements in immunoassay development. The company is poised to leverage this capital to solidify its standing as a key provider of reliable diagnostic tools for clinical and research applications.
See full Epitope Diagnostics company page
